Global Anti-Inflammatory Therapeutics Market 2024-2028
The anti-inflammatory therapeutics market is forecasted to grow by USD 38.7 bn during 2023-2028, accelerating at a CAGR of 6.3% during the forecast period. The report on the anti-inflammatory therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in off-label use, unmet needs for safer biologics for RA, and availability of improved diagnostic modalities.
Technavio's anti-inflammatory therapeutics market is segmented as below:
By Application
By Drug Class
- Anti-inflammatory biologicals
- Corticosteroids
- NSAIDs
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the emergence of novel anti-inflammatory drugs as one of the prime reasons driving the anti-inflammatory therapeutics market growth during the next few years. Also, use of gene therapy for RA treatment and market dominance by tnf-alpha inhibitors will lead to sizable demand in the market.
The report on the anti-inflammatory therapeutics market covers the following areas:
- Anti-inflammatory therapeutics market sizing
- Anti-inflammatory therapeutics market forecast
- Anti-inflammatory therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-inflammatory therapeutics market vendors that include AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Ferring BV, GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Viatris Inc., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Novartis AG. Also, the anti-inflammatory therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.